Education | Tissuepathology.com

Join Indica Labs for Next Week’s Webinar

Erica Goodpaster — Fri, 06 Nov 2026 13:31:05 +0000

Indica Labs: Learn how HALO Link enables a centralized digital pathology workflow designed to support biomarker and translational research From Image to Insight: Automating Biomarker Research Workflows with HALO Link Date: 19 November 2026 Time: 8:00 – 9:00 EST | 13:00 – 14:00 GMT | 14:00 – 15:00 CET Location: Webinar Register Now Summary Digital […]

The post Join Indica Labs for Next Week’s Webinar first appeared on Tissuepathology.com.

Aiforia Announces Webinar for November 4

Erica Goodpaster — Fri, 23 Oct 2026 13:05:08 +0000

AI models in GI/liver pathology using the Aiforia Platform Quantitative and predictive AI models in gastrointestinal and liver pathology: the Mayo Clinic experience 4 November 2026 – 12:00 PM (noon) EST REGISTER NOW Over the past 5 years, researchers and pathologists at Mayo Clinic have spearheaded the development of advanced artificial intelligence (AI) models across […]

The post Aiforia Announces Webinar for November 4 first appeared on Tissuepathology.com.

Indica Labs Announces Webinar for November

Erica Goodpaster — Wed, 21 Oct 2026 10:51:31 +0000

Indica Labs: Learn About AI Model Interoperability with HALO AI Open AI Workflows in Digital Pathology: Model Interoperability with HALO® Date: 4 November 2026 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT Location: Webinar Register Now Summary As artificial intelligence becomes increasingly integrated into digital pathology, interoperability between […]

The post Indica Labs Announces Webinar for November first appeared on Tissuepathology.com.

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Erica Goodpaster — Mon, 19 Oct 2026 12:41:31 +0000

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM) today announced results from a study evaluating an AI-enabled pre-screening panel for patients with advanced non-small cell lung cancer (NSCLC). The panel […]

The post Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC first appeared on Tissuepathology.com.

Deciphex CEO at International AI Summit in Dublin

Erica Goodpaster — Fri, 16 Oct 2026 11:51:30 +0000

From Deciphex on LinkedIn: Our founder and CEO Donal O’Shea was on stage at the International AI Summit in Dublin yesterday, the flagship AI event of Ireland’s EU Council Presidency. He joined Áine Kerr, Dorothy Creaven (Jentic), Eoin Hinchy (Tines) and Guillaume Princen (Anthropic) on the panel “Developing Global AI Leaders: From Start-ups to Scale-ups”. […]

The post Deciphex CEO at International AI Summit in Dublin first appeared on Tissuepathology.com.

Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026

Erica Goodpaster — Tue, 06 Oct 2026 13:10:30 +0000

Agendia Podium presentation by Co-Founder and Chief Research Officer Laura van ’t Veer introduces an AI-driven approach to MammaPrint Two additional poster presentations from the FLEX Study IRVINE, Calif. & AMSTERDAM–(BUSINESS WIRE)–Agendia, Inc., a leader in precision oncology for breast cancer, announced today that it will present new research during a podium presentation on the […]

The post Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026 first appeared on Tissuepathology.com.